nodes	percent_of_prediction	percent_of_DWPC	metapath
Famotidine—SLC22A2—Neurotransmitter Release Cycle—MAOA—Parkinson's disease	0.00599	0.00599	CbGpPWpGaD
Famotidine—HRH2—G alpha (s) signalling events—DRD1—Parkinson's disease	0.00592	0.00592	CbGpPWpGaD
Famotidine—SLC22A2—Transmission across Chemical Synapses—KCNJ4—Parkinson's disease	0.00558	0.00558	CbGpPWpGaD
Famotidine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC18A2—Parkinson's disease	0.00553	0.00553	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—GPR37—Parkinson's disease	0.00551	0.00551	CbGpPWpGaD
Famotidine—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—Parkinson's disease	0.00522	0.00522	CbGpPWpGaD
Famotidine—HRH2—G alpha (s) signalling events—HTR7—Parkinson's disease	0.00519	0.00519	CbGpPWpGaD
Famotidine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—Parkinson's disease	0.00509	0.00509	CbGpPWpGaD
Famotidine—SLC47A1—SLC-mediated transmembrane transport—SLC6A3—Parkinson's disease	0.00503	0.00503	CbGpPWpGaD
Famotidine—SLC22A2—Transmission across Chemical Synapses—DLG1—Parkinson's disease	0.00481	0.00481	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—PENK—Parkinson's disease	0.00466	0.00466	CbGpPWpGaD
Famotidine—CYP2C19—Melatonin metabolism and effects—MAOA—Parkinson's disease	0.00451	0.00451	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—KCNJ4—Parkinson's disease	0.00427	0.00427	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—PDYN—Parkinson's disease	0.00426	0.00426	CbGpPWpGaD
Famotidine—CYP2C19—Melatonin metabolism and effects—EDN1—Parkinson's disease	0.0042	0.0042	CbGpPWpGaD
Famotidine—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—Parkinson's disease	0.00395	0.00395	CbGpPWpGaD
Famotidine—HRH2—GPCRs, Class A Rhodopsin-like—ADORA2A—Parkinson's disease	0.00393	0.00393	CbGpPWpGaD
Famotidine—SLC47A1—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.0039	0.0039	CbGpPWpGaD
Famotidine—SLC22A2—Transmission across Chemical Synapses—GRIK1—Parkinson's disease	0.00377	0.00377	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—GRM4—Parkinson's disease	0.00374	0.00374	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—DLG1—Parkinson's disease	0.00369	0.00369	CbGpPWpGaD
Famotidine—CYP2C19—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.00365	0.00365	CbGpPWpGaD
Famotidine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—Parkinson's disease	0.00363	0.00363	CbGpPWpGaD
Famotidine—SLC22A8—SLC-mediated transmembrane transport—SLC18A2—Parkinson's disease	0.00361	0.00361	CbGpPWpGaD
Famotidine—SLC47A1—Transmembrane transport of small molecules—CP—Parkinson's disease	0.00359	0.00359	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—PENK—Parkinson's disease	0.00355	0.00355	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.00346	0.00346	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.00346	0.00346	CbGpPWpGaD
Famotidine—CYP2C19—Melatonin metabolism and effects—APOE—Parkinson's disease	0.00341	0.00341	CbGpPWpGaD
Famotidine—HRH2—GPCRs, Class A Rhodopsin-like—HTR1A—Parkinson's disease	0.00341	0.00341	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—ADORA2A—Parkinson's disease	0.00337	0.00337	CbGpPWpGaD
Famotidine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.00335	0.00335	CbGpPWpGaD
Famotidine—SLC22A8—SLC-mediated transmembrane transport—CP—Parkinson's disease	0.00333	0.00333	CbGpPWpGaD
Famotidine—CYP2C19—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.0033	0.0033	CbGpPWpGaD
Famotidine—HRH2—GPCRs, Class A Rhodopsin-like—DRD1—Parkinson's disease	0.0033	0.0033	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—PDYN—Parkinson's disease	0.00325	0.00325	CbGpPWpGaD
Famotidine—SLC22A2—Transmission across Chemical Synapses—GRIK2—Parkinson's disease	0.0032	0.0032	CbGpPWpGaD
Famotidine—HRH2—GPCRs, Class A Rhodopsin-like—DRD3—Parkinson's disease	0.00319	0.00319	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—DGKQ—Parkinson's disease	0.00311	0.00311	CbGpPWpGaD
Famotidine—SLC22A2—Transmission across Chemical Synapses—SLC18A2—Parkinson's disease	0.0031	0.0031	CbGpPWpGaD
Famotidine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.00306	0.00306	CbGpPWpGaD
Famotidine—CYP2C19—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.00302	0.00302	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—GRM5—Parkinson's disease	0.00302	0.00302	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—HTR1A—Parkinson's disease	0.00292	0.00292	CbGpPWpGaD
Famotidine—HRH2—GPCRs, Class A Rhodopsin-like—HTR7—Parkinson's disease	0.00289	0.00289	CbGpPWpGaD
Famotidine—HRH2—GPCRs, Class A Rhodopsin-like—DRD2—Parkinson's disease	0.00289	0.00289	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—GRIK1—Parkinson's disease	0.00289	0.00289	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—TAC1—Parkinson's disease	0.00288	0.00288	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—DGKQ—Parkinson's disease	0.00283	0.00283	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—GPR37—Parkinson's disease	0.00283	0.00283	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	0.00282	0.00282	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	0.00273	0.00273	CbGpPWpGaD
Famotidine—CYP2C19—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.00271	0.00271	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.00259	0.00259	CbGpPWpGaD
Famotidine—CYP2C19—Arachidonic acid metabolism—GPX1—Parkinson's disease	0.00257	0.00257	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—ADORA2A—Parkinson's disease	0.00257	0.00257	CbGpPWpGaD
Famotidine—SLC47A1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.00256	0.00256	CbGpPWpGaD
Famotidine—SLC22A2—SLC-mediated transmembrane transport—SLC18A2—Parkinson's disease	0.00251	0.00251	CbGpPWpGaD
Famotidine—CYP2C19—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.00248	0.00248	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	0.00247	0.00247	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	0.00247	0.00247	CbGpPWpGaD
Famotidine—SLC22A2—Transmission across Chemical Synapses—CHRNA4—Parkinson's disease	0.00245	0.00245	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—GRIK2—Parkinson's disease	0.00245	0.00245	CbGpPWpGaD
Famotidine—SLC47A1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.00245	0.00245	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.00241	0.00241	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.00241	0.00241	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—SLC18A2—Parkinson's disease	0.00238	0.00238	CbGpPWpGaD
Famotidine—SLC22A8—SLC-mediated transmembrane transport—SLC6A3—Parkinson's disease	0.00237	0.00237	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—GRK5—Parkinson's disease	0.00236	0.00236	CbGpPWpGaD
Famotidine—SLC22A2—SLC-mediated transmembrane transport—CP—Parkinson's disease	0.00231	0.00231	CbGpPWpGaD
Famotidine—SLC22A2—Transmission across Chemical Synapses—HSPA8—Parkinson's disease	0.00225	0.00225	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—HTR1A—Parkinson's disease	0.00223	0.00223	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—TAC1—Parkinson's disease	0.00219	0.00219	CbGpPWpGaD
Famotidine—CYP2C19—Biological oxidations—GSTA4—Parkinson's disease	0.00218	0.00218	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—DRD1—Parkinson's disease	0.00215	0.00215	CbGpPWpGaD
Famotidine—CYP2C19—Metapathway biotransformation—GSTA4—Parkinson's disease	0.00215	0.00215	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—GRK5—Parkinson's disease	0.00214	0.00214	CbGpPWpGaD
Famotidine—SLC47A1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.00213	0.00213	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—GRM4—Parkinson's disease	0.00212	0.00212	CbGpPWpGaD
Famotidine—SLC22A2—Transmission across Chemical Synapses—DLG4—Parkinson's disease	0.00211	0.00211	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—DRD3—Parkinson's disease	0.00208	0.00208	CbGpPWpGaD
Famotidine—SLC22A2—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	0.00206	0.00206	CbGpPWpGaD
Famotidine—SLC47A1—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.00205	0.00205	CbGpPWpGaD
Famotidine—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.00204	0.00204	CbGpPWpGaD
Famotidine—SLC22A2—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	0.00203	0.00203	CbGpPWpGaD
Famotidine—HRH2—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.00202	0.00202	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—VPS35—Parkinson's disease	0.00202	0.00202	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—PENK—Parkinson's disease	0.00201	0.00201	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.00198	0.00198	CbGpPWpGaD
Famotidine—CYP2C19—Biological oxidations—MAOB—Parkinson's disease	0.00194	0.00194	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—GRM4—Parkinson's disease	0.00192	0.00192	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—HTR7—Parkinson's disease	0.00188	0.00188	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—DRD2—Parkinson's disease	0.00188	0.00188	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—CHRNA4—Parkinson's disease	0.00188	0.00188	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.00184	0.00184	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—PDYN—Parkinson's disease	0.00183	0.00183	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—PENK—Parkinson's disease	0.00182	0.00182	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.00173	0.00173	CbGpPWpGaD
Famotidine—SLC22A2—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.00173	0.00173	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—HSPA8—Parkinson's disease	0.00172	0.00172	CbGpPWpGaD
Famotidine—SLC22A2—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.00172	0.00172	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—GRM5—Parkinson's disease	0.00171	0.00171	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—CP—Parkinson's disease	0.00169	0.00169	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—DGKQ—Parkinson's disease	0.00167	0.00167	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—GPR37—Parkinson's disease	0.00167	0.00167	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—PDYN—Parkinson's disease	0.00167	0.00167	CbGpPWpGaD
Famotidine—SLC22A2—SLC-mediated transmembrane transport—SLC6A3—Parkinson's disease	0.00165	0.00165	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—DLG4—Parkinson's disease	0.00162	0.00162	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—GRIN2B—Parkinson's disease	0.00158	0.00158	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—SLC6A3—Parkinson's disease	0.00156	0.00156	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—GRM5—Parkinson's disease	0.00155	0.00155	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PPP1R1B—Parkinson's disease	0.00153	0.00153	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—EDN1—Parkinson's disease	0.00151	0.00151	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.00145	0.00145	CbGpPWpGaD
Famotidine—CYP2C19—Biological oxidations—CYP2D6—Parkinson's disease	0.00144	0.00144	CbGpPWpGaD
Famotidine—CYP2C19—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.00142	0.00142	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—RIT2—Parkinson's disease	0.00133	0.00133	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—COMT—Parkinson's disease	0.00133	0.00133	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—HTR2A—Parkinson's disease	0.00132	0.00132	CbGpPWpGaD
Famotidine—CYP2C19—Biological oxidations—CYP2E1—Parkinson's disease	0.00132	0.00132	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—ADORA2A—Parkinson's disease	0.00132	0.00132	CbGpPWpGaD
Famotidine—SLC22A2—Neuronal System—MAOA—Parkinson's disease	0.00132	0.00132	CbGpPWpGaD
Famotidine—CYP2C19—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.0013	0.0013	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.00128	0.00128	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—GRK5—Parkinson's disease	0.00127	0.00127	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—MCCC1—Parkinson's disease	0.00127	0.00127	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—ND3—Parkinson's disease	0.00127	0.00127	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—HTR1A—Parkinson's disease	0.00126	0.00126	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—TAC1—Parkinson's disease	0.00124	0.00124	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—DRD1—Parkinson's disease	0.00122	0.00122	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.00121	0.00121	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.0012	0.0012	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—OMD—Parkinson's disease	0.00119	0.00119	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—TALDO1—Parkinson's disease	0.00119	0.00119	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—DRD3—Parkinson's disease	0.00118	0.00118	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—CP—Parkinson's disease	0.00118	0.00118	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.00116	0.00116	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—HTR1A—Parkinson's disease	0.00114	0.00114	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—GRM4—Parkinson's disease	0.00114	0.00114	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—NDUFB11—Parkinson's disease	0.00113	0.00113	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—TAC1—Parkinson's disease	0.00113	0.00113	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—DRD1—Parkinson's disease	0.0011	0.0011	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.0011	0.0011	CbGpPWpGaD
Famotidine—CYP2C19—Biological oxidations—COMT—Parkinson's disease	0.00109	0.00109	CbGpPWpGaD
Famotidine—CYP2C19—Biological oxidations—GSTP1—Parkinson's disease	0.00109	0.00109	CbGpPWpGaD
Famotidine—CYP2C19—Biological oxidations—MAOA—Parkinson's disease	0.00108	0.00108	CbGpPWpGaD
Famotidine—CYP2C19—Metapathway biotransformation—COMT—Parkinson's disease	0.00108	0.00108	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PENK—Parkinson's disease	0.00108	0.00108	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—MAG—Parkinson's disease	0.00108	0.00108	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—GCH1—Parkinson's disease	0.00108	0.00108	CbGpPWpGaD
Famotidine—CYP2C19—Metapathway biotransformation—GSTP1—Parkinson's disease	0.00107	0.00107	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—DRD3—Parkinson's disease	0.00107	0.00107	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—DRD2—Parkinson's disease	0.00106	0.00106	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—HTR7—Parkinson's disease	0.00106	0.00106	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.00101	0.00101	CbGpPWpGaD
Famotidine—CYP2C19—Biological oxidations—GSTM1—Parkinson's disease	0.000999	0.000999	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000998	0.000998	CbGpPWpGaD
Famotidine—CYP2C19—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000985	0.000985	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PDYN—Parkinson's disease	0.000984	0.000984	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—HTR7—Parkinson's disease	0.000967	0.000967	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—DRD2—Parkinson's disease	0.000967	0.000967	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000965	0.000965	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—DBH—Parkinson's disease	0.000959	0.000959	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—GBA—Parkinson's disease	0.000959	0.000959	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—FBP1—Parkinson's disease	0.000959	0.000959	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—GFAP—Parkinson's disease	0.000925	0.000925	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—GRM5—Parkinson's disease	0.000915	0.000915	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—EDN1—Parkinson's disease	0.000852	0.000852	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000838	0.000838	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000805	0.000805	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—FGF20—Parkinson's disease	0.000802	0.000802	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—ADORA2A—Parkinson's disease	0.000778	0.000778	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—EDN1—Parkinson's disease	0.000774	0.000774	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.000752	0.000752	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000745	0.000745	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—INSR—Parkinson's disease	0.000718	0.000718	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—MCCC1—Parkinson's disease	0.000708	0.000708	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ND3—Parkinson's disease	0.000708	0.000708	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—DDC—Parkinson's disease	0.000704	0.000704	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000699	0.000699	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—FGB—Parkinson's disease	0.000679	0.000679	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—HTR2A—Parkinson's disease	0.000677	0.000677	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—HTR1A—Parkinson's disease	0.000675	0.000675	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000671	0.000671	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—OMD—Parkinson's disease	0.000666	0.000666	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—TALDO1—Parkinson's disease	0.000666	0.000666	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—TAC1—Parkinson's disease	0.000665	0.000665	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—GSTA4—Parkinson's disease	0.000665	0.000665	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—DRD1—Parkinson's disease	0.000652	0.000652	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—DRD3—Parkinson's disease	0.000631	0.000631	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—NDUFB11—Parkinson's disease	0.000631	0.000631	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GCH1—Parkinson's disease	0.000602	0.000602	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PLA2G6—Parkinson's disease	0.000599	0.000599	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—MAOB—Parkinson's disease	0.000592	0.000592	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—ADRBK1—Parkinson's disease	0.00059	0.00059	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—DRD2—Parkinson's disease	0.000571	0.000571	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—HTR7—Parkinson's disease	0.000571	0.000571	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.000543	0.000543	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—FBP1—Parkinson's disease	0.000537	0.000537	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GBA—Parkinson's disease	0.000537	0.000537	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—DBH—Parkinson's disease	0.000537	0.000537	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—IGF2—Parkinson's disease	0.000478	0.000478	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—IGF1R—Parkinson's disease	0.000463	0.000463	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—EDN1—Parkinson's disease	0.000457	0.000457	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CYP2D6—Parkinson's disease	0.00044	0.00044	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CTGF—Parkinson's disease	0.000432	0.000432	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—NGF—Parkinson's disease	0.00042	0.00042	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CYP2E1—Parkinson's disease	0.000403	0.000403	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—HTR2A—Parkinson's disease	0.0004	0.0004	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—NQO1—Parkinson's disease	0.000398	0.000398	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—DDC—Parkinson's disease	0.000394	0.000394	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—TH—Parkinson's disease	0.000392	0.000392	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CYCS—Parkinson's disease	0.000377	0.000377	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GSTA4—Parkinson's disease	0.000372	0.000372	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—APOE—Parkinson's disease	0.000372	0.000372	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000367	0.000367	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PLA2G6—Parkinson's disease	0.000335	0.000335	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—COMT—Parkinson's disease	0.000334	0.000334	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—GSTP1—Parkinson's disease	0.000332	0.000332	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—MAOB—Parkinson's disease	0.000332	0.000332	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—MAOA—Parkinson's disease	0.000331	0.000331	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—HMOX1—Parkinson's disease	0.000328	0.000328	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—INS—Parkinson's disease	0.000318	0.000318	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000316	0.000316	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—ABCB1—Parkinson's disease	0.000314	0.000314	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—GSTM1—Parkinson's disease	0.000305	0.000305	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—GPX1—Parkinson's disease	0.000292	0.000292	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—MTHFR—Parkinson's disease	0.00027	0.00027	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—APOE—Parkinson's disease	0.000251	0.000251	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CYP2D6—Parkinson's disease	0.000246	0.000246	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CTGF—Parkinson's disease	0.000242	0.000242	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CASP3—Parkinson's disease	0.000236	0.000236	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—IL6—Parkinson's disease	0.000235	0.000235	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CYP2E1—Parkinson's disease	0.000225	0.000225	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—NQO1—Parkinson's disease	0.000223	0.000223	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—TH—Parkinson's disease	0.00022	0.00022	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—MAPK8—Parkinson's disease	0.000217	0.000217	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—INS—Parkinson's disease	0.000215	0.000215	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CYCS—Parkinson's disease	0.000211	0.000211	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—COMT—Parkinson's disease	0.000187	0.000187	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GSTP1—Parkinson's disease	0.000186	0.000186	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—MAOA—Parkinson's disease	0.000185	0.000185	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—HMOX1—Parkinson's disease	0.000183	0.000183	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ABCB1—Parkinson's disease	0.000176	0.000176	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GSTM1—Parkinson's disease	0.000171	0.000171	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GPX1—Parkinson's disease	0.000164	0.000164	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—MTHFR—Parkinson's disease	0.000151	0.000151	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—APOE—Parkinson's disease	0.000141	0.000141	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—IL6—Parkinson's disease	0.000139	0.000139	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—INS—Parkinson's disease	0.00012	0.00012	CbGpPWpGaD
